A detailed history of Time Scale Financial, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Time Scale Financial, Inc. holds 470 shares of BMY stock, worth $24,750. This represents 0.01% of its overall portfolio holdings.

Number of Shares
470
Previous 1,281 63.31%
Holding current value
$24,750
Previous $88,000 65.91%
% of portfolio
0.01%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 26, 2023

SELL
$63.71 - $70.74 $51,668 - $57,370
-811 Reduced 63.31%
470 $30,000
Q1 2023

Apr 21, 2023

BUY
$65.71 - $74.53 $42,054 - $47,699
640 Added 99.84%
1,281 $88,000
Q2 2022

Jul 25, 2022

SELL
$72.62 - $79.98 $72,692 - $80,059
-1,001 Reduced 60.96%
641 $49,000
Q1 2022

Apr 18, 2022

BUY
$61.48 - $73.72 $3,135 - $3,759
51 Added 3.21%
1,642 $120,000
Q4 2021

Jan 19, 2022

BUY
$53.63 - $62.52 $53 - $62
1 Added 0.06%
1,591 $99,000
Q3 2021

Nov 10, 2021

SELL
$59.17 - $69.31 $59 - $69
-1 Reduced 0.06%
1,590 $94,000
Q2 2021

Jul 26, 2021

SELL
$61.91 - $67.42 $5,881 - $6,404
-95 Reduced 5.63%
1,591 $106,000
Q1 2021

Apr 22, 2021

BUY
$59.34 - $66.74 $237 - $266
4 Added 0.24%
1,686 $106,000
Q4 2020

Jan 28, 2021

SELL
$57.74 - $65.43 $46,307 - $52,474
-802 Reduced 32.29%
1,682 $104,000
Q3 2020

Oct 07, 2020

SELL
$57.43 - $63.64 $12,806 - $14,191
-223 Reduced 8.24%
2,484 $149,000
Q1 2020

Apr 09, 2020

SELL
$46.4 - $67.43 $7,795 - $11,328
-168 Reduced 5.84%
2,707 $150,000
Q4 2019

Jan 28, 2020

BUY
$49.21 - $64.19 $44,436 - $57,963
903 Added 45.79%
2,875 $184,000
Q2 2019

Jul 31, 2019

BUY
$44.62 - $49.34 $87,990 - $97,298
1,972 New
1,972 $89,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $112B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Time Scale Financial, Inc. Portfolio

Follow Time Scale Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Time Scale Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Time Scale Financial, Inc. with notifications on news.